1,2-Dihydrobudesonide is a synthetic glucocorticosteroid that has a molecular structure similar to prednisolone. It is used for the treatment of inflammatory skin conditions such as eczema and psoriasis. 1,2-Dihydrobudesonide has been shown to have a high oral bioavailability and low systemic bioavailability. The molecule is metabolized in the liver to produce hydrocortisone, which accounts for its oral bioavailability. 1,2-Dihydrobudesonide is classified as an acetal because it contains an acetal linkage between the 16-carbon (C16) steroid nucleus and the 17-carbon (C17) side chain. This connection results in a more stable molecule than desonide, which is not acetalated. In vitro data indicates that 1,2-dihydrobudesonide has a lower binding affinity with human liver cytosolic receptors than des

Specification

MSDS

TSE / BSE Statement

Retest Statement

• liver, biotransformation, human, human liver, rat liver, fluorination, metabolism, budesonide, vitro, data, acetal, prednisolone, molecule, desonide, structural, hydrogenation, group, effect, vitro results, vitro data, hydrocortisone, steroid, groups, results, nucleus, symmetric, bioavailability, glucocorticosteroids, correlate, Show more, oral bioavailability supernatant, steroid nucleus, marginally, Show less